The EPO published patent EP3972428A1 titled 'Dietary Butyrate and Its Uses' for Nestlé, covering compositions containing butyrate for therapeutic applications including bone health (A61P 19/08). The application includes IPC classifications spanning food compositions (A23L 33/00), nutritional formulations (A23K 20/158), and lipid compositions (C11C 3/00). Designated contracting states cover all major European markets.

This patent publication grants Nestlé enforceable intellectual property rights over dietary butyrate formulations and their therapeutic applications in designated territories. Competitors developing butyrate-based nutritional or therapeutic products should conduct freedom-to-operate analyses and consider licensing discussions with Nestlé. No immediate compliance actions are required beyond standard IP due diligence for R&D activities in this field.